NCT01878695View on ClinicalTrials.gov

Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 26, 2012

Primary Completion Date

May 14, 2015

Study Completion Date

May 14, 2015

Conditions
Stage 0/1 Breast CancerPost BiopsyPre-surgery
Interventions
DRUG

IV/oral n-acetylcysteine

Trial Locations (1)

19107

Jefferson Myrna Brind Center for Integrative Medicine, Philadelphia

All Listed Sponsors
lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT01878695 - Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer | Biotech Hunter | Biotech Hunter